Growing community of inventors

Newmarket, Canada

Andrew Darke

Average Co-Inventor Count = 2.22

ph-index = 8

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 344

Andrew DarkeThinnayam Naganathan Krishnamurthy (12 patents)Andrew DarkeRichard S Sackler (2 patents)Andrew DarkePaul D Goldenheim (2 patents)Andrew DarkeBenjamin Oshlack (1 patent)Andrew DarkeBenjamin Oshlaci (1 patent)Andrew DarkeAndrew Darke (12 patents)Thinnayam Naganathan KrishnamurthyThinnayam Naganathan Krishnamurthy (18 patents)Richard S SacklerRichard S Sackler (48 patents)Paul D GoldenheimPaul D Goldenheim (37 patents)Benjamin OshlackBenjamin Oshlack (157 patents)Benjamin OshlaciBenjamin Oshlaci (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Rhodes Pharmaceuticals L.p. (5 from 10 patents)

2. Purdue Pharma L.p. (4 from 545 patents)

3. Euro-Celtique S.a. (3 from 270 patents)


12 patents:

1. 10463624 - Controlled release formulations

2. 10039719 - Methods of treating attention deficit hyperactivity disorder

3. 10022330 - Methods of preparing oral controlled release formulations

4. 9949931 - Methods of treating attention deficit hyperactivity disorder

5. 9801823 - Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations

6. 9066869 - Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations

7. 8580310 - Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations

8. 7438930 - Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations

9. 7247318 - Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations

10. 7083808 - Controlled/modified release oral methylphenidate formulations

11. 6673367 - Controlled/modified release oral methylphenidate formulations

12. 6419960 - Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/7/2026
Loading…